Loading stock data...

Crestchem Limited

BSE: CRSTCHM

BSE
131.75 -10.75 (-7.54%)

Prev Close

142.5

Open Price

135

Volume

4,698

Today Low / High

130.25 / 138.95

52 WK Low / High

130.25 / 329

Range

125 - 138

The stock is currently available for trading on the Bombay Stock Exchange (BSE). Its price is 131.75, reflecting a change of -10.75 (-7.54386%). The expected target range on the BSE is 125 - 138. The stock is showing a downward trend on the BSE. This could indicate a potential risk for investors who are considering buying at this moment.

08 Aug 150.00 0.33%
07 Aug 158.00 -3.29%
06 Aug 168.50 -6.77%
05 Aug 170.00 -5.35%
04 Aug 169.95 -2.91%
01 Aug 175.00 -7.49%
31 Jul 174.40 -2.55%
30 Jul 168.90 -1.48%
29 Jul 160.00 0.63%
28 Jul 157.85 -1.20%
25 Jul 165.05 -3.39%
24 Jul 161.05 2.45%
23 Jul 170.00 -1.50%
22 Jul 172.90 -3.99%
21 Jul 178.90 -5.90%

Crestchem Limited Graph

Crestchem Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges

If you are looking for the target price for Crestchem Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 131.75, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.

Scenario Price Target Range
Bullish Scenario 131.75 133.07 119.76 - 146.37
134.39 107.51 - 161.26
135.70 94.99 - 176.41
Bearish Scenario 131.75 130.43 117.39 - 143.48
129.12 103.29 - 154.94
127.80 89.46 - 166.14

Overview of Crestchem Limited

ISIN

INE293N01016

Industry

Medical - Pharmaceuticals

Vol.Avg

1,772

Market Cap

451,500,000

Last Dividend

1

Official Website

Visit Website

IPO Date

1998-12-30

DCF Diff

-263.42

DCF

448

Financial Ratios Every Investor Needs

Stock Dividend of CRSTCHM

Date Label Adj Dividend Dividend Record Date Payment Date Declaration Date
2025-08-13 August 13, 25 1 1 2025-08-13 2025-09-20
2024-08-23 August 23, 24 0.5 0.5 2024-08-23 2024-09-29

Stock Rating Details for CRSTCHM

Metric Value Recommendation
Overall Rating B+ Neutral
DCF Score 5 Strong Buy
ROE Score 5 Strong Buy
ROA Score 5 Strong Buy
Debt-to-Equity (DE) Score 1 Strong Sell
Price-to-Earnings (PE) Score 2 Sell
Price-to-Book (PB) Score 1 Strong Sell

Annual Financial Income Report

Date Revenue Co.Rev GP GPR R&D Expenses G&A Expenses Operating Income Net Income EPS EBITDA NIR
2025-03-31 25.08 Cr 19.98 Cr 5.10 Cr 0.2033 0.00 Cr 0.00 Cr 3.23 Cr 2.73 Cr 9.08 3.72 Cr 0.1087
2024-03-31 21.18 Cr 16.10 Cr 5.08 Cr 0.2398 0.11 Cr 0.20 Cr 2.73 Cr 2.15 Cr 7.15 3.03 Cr 0.1013
2023-03-31 16.73 Cr 14.44 Cr 2.29 Cr 0.1367 0.00 Cr 0.13 Cr 0.81 Cr 0.69 Cr 2.31 0.97 Cr 0.0415
2022-03-31 7.95 Cr 6.13 Cr 1.82 Cr 0.2287 0.00 Cr 0.16 Cr 0.73 Cr 0.57 Cr 1.89 0.82 Cr 0.0714
2021-03-31 7.51 Cr 5.82 Cr 1.69 Cr 0.2249 0.00 Cr 0.08 Cr 0.64 Cr 0.57 Cr 1.91 0.71 Cr 0.0765

Annual Financials Balance Sheet

Date C&C Equ. Tot. Assets Tot. Liab. Stock. Equity Tot. Debt Net Debt Inv. PP&E (Net) Curr. Def. Rev. Non-Curr. Def. Rev. LT Invest. Curr. Liab.
2025-03-31 0.73 Cr 10.54 Cr 3.07 Cr 7.4760 Cr 0.00 Cr -0.73 Cr 0.00 Cr 0.26 Cr 0.00 Cr 0.00 Cr 5.88 Cr 2.9974 Cr
2024-03-31 0.15 Cr 7.14 Cr 2.24 Cr 4.7495 Cr 0.00 Cr -0.15 Cr 0.00 Cr 0.17 Cr 0.00 Cr 0.00 Cr 4.60 Cr 2.2093 Cr
2023-03-31 0.87 Cr 4.79 Cr 2.03 Cr 2.7532 Cr 0.00 Cr -0.87 Cr -0.04 Cr 0.11 Cr 0.00 Cr 0.00 Cr 3.39 Cr 2.0212 Cr
2022-03-31 0.01 Cr 3.29 Cr 1.23 Cr 2.0597 Cr 0.27 Cr 0.26 Cr 0.00 Cr 0.19 Cr 0.21 Cr 0.00 Cr 1.93 Cr 1.2274 Cr
2021-03-31 0.03 Cr 3.00 Cr 1.51 Cr 1.4925 Cr 0.63 Cr 0.59 Cr 0.00 Cr 0.21 Cr 0.36 Cr 0.00 Cr 0.09 Cr 1.4561 Cr

Annual Financials Cash Flow Statement

Date Operating Cash Investing Cash Financing Cash Free Cash Cash Change Cash at End CapEx Income Debt Repay Dividends Inventory
2025-03-31 2.0870 Cr -1.4257 Cr -0.0747 Cr 1.9465 Cr 0.0000 Cr 0.7315 Cr -0.1405 Cr 2.7265 Cr 0.0000 Cr -0.0747 Cr -0.0003 Cr
2024-03-31 0.5941 Cr -1.3183 Cr -0.0071 Cr 0.4790 Cr -0.7241 Cr 0.1450 Cr -0.1151 Cr 2.1463 Cr 0.0000 Cr 0.0000 Cr 0.0000 Cr
2023-03-31 2.2106 Cr -1.3414 Cr -0.0098 Cr 2.1946 Cr 0.8594 Cr 0.8691 Cr -0.0160 Cr 0.9382 Cr 0.0000 Cr 0.0000 Cr 0.0025 Cr
2022-03-31 0.8188 Cr -0.8279 Cr -0.0158 Cr 0.8184 Cr -0.0248 Cr 0.0097 Cr -0.0004 Cr 0.7812 Cr 0.0000 Cr 0.0000 Cr 0.0006 Cr
2021-03-31 0.3935 Cr -0.3911 Cr -0.0161 Cr -0.0151 Cr -0.0136 Cr 0.0345 Cr -0.4086 Cr 0.6733 Cr 0.0000 Cr 0.0000 Cr 0.0032 Cr

Quarterly Financial Income Report

Date Revenue Co.Rev GP GPR Operating Income Net Income EPS EBITDA NIR
2025-03-31 7.37 Cr 5.77 Cr 1.61 Cr 0.2177 1.23 Cr 0.61 Cr 2.03 0.74 Cr 0.0828
2024-12-31 4.80 Cr 3.60 Cr 1.19 Cr 0.2490 0.64 Cr 0.52 Cr 1.74 0.74 Cr 0.1087
2024-09-30 7.80 Cr 5.58 Cr 2.22 Cr 0.2843 1.27 Cr 1.00 Cr 3.32 1.28 Cr 0.1278
2024-06-30 5.25 Cr 4.06 Cr 1.18 Cr 0.2257 0.75 Cr 0.60 Cr 1.99 0.84 Cr 0.1140
2024-03-31 5.63 Cr 4.37 Cr 1.26 Cr 0.2241 0.84 Cr 0.66 Cr 2.21 0.94 Cr 0.1176

Quarterly Financials Balance Sheet

Date Cash & Equiv. Short-Term Inv. Cash & Short-Term Net Receivables Inventory Total Curr. Assets PP&E (Net) Total Assets Total Liabilities
2025-03-31 0.73 Cr 0.00 Cr 0.73 Cr 2.56 Cr 0.00 Cr 4.31 Cr 0.26 Cr 10.54 Cr 3.07 Cr
2024-12-31 0.00 Cr 0.00 Cr 0.14 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr -6.34 Cr
2024-09-30 0.14 Cr 0.00 Cr 0.14 Cr 1.54 Cr 0.00 Cr 2.15 Cr 0.17 Cr 8.07 Cr 1.73 Cr
2024-06-30 0.00 Cr 0.00 Cr 0.15 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr -4.90 Cr
2024-03-31 0.15 Cr 0.00 Cr 0.15 Cr 0.00 Cr 0.00 Cr 2.29 Cr 0.17 Cr 7.14 Cr 2.24 Cr

Quarterly Financials Cash Flow Statement

Date Net Income Operating Cash Flow Investing Cash Flow Financing Cash Flow Net Cash Change Cash at End Cash at Beginning CapEx Free Cash Flow
2024-12-31 0.52 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-09-30 1.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-06-30 0.60 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-03-31 0.66 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2023-12-31 0.91 Cr 0.03 Cr 0.00 Cr 0.00 Cr 0.03 Cr 1.71 Cr 1.68 Cr 0.00 Cr 0.03 Cr

Splits History

Date Label Split Ratio
No split history data available.

Similar Stocks: Medical - Pharmaceuticals

Company Name Symbol Price Market Cap Volume
MedPlus Health Services Limited MEDPLUS ₹804.05 ₹96,279,696,851.00 ₹756,659.00

Key Executives

Manager of Finance & Accounts
Mr. Satish D. Panchal

Gender: male

Year Born:

Manager of Administration
Ms. Parul Dipak Patel

Gender: female

Year Born:

Chairman & MD
Mr. Dipak Narendraprasad Patel B.Sc., M.B.A.

Gender: male

Year Born: 1955

Chief Financial Officer, Company Secretary & Compliance Officer
Ms. Khyati Dipakkumar Vyas

Gender: female

Year Born:

FAQs about Crestchem Limited

Who is the CEO of the company?

The CEO is Dipak Narendraprasad Patel.

What is the current market price of the stock?

The current price is ₹150.50.

What is the 52-week price range?

The range is ₹146.3-329.

What is the market capitalization of the company?

The market capitalization is ₹45.15 crores.

What is the dividend yield?

The dividend yield is 0.33%.

What is the Price-to-Earnings (P/E) ratio?

The P/E ratio is 16.60.

Which sector does the company belong to?

The company operates in the Healthcare sector.

What does the company do?

Overview of Crestchem Limited (ISIN: INE293N01016) is a leading Medical - Pharmaceuticals in India. With a market capitalization of ₹45.15 crores and an average daily volume of 1,772 shares, it operates in the Medical - Pharmaceuticals. The company last declared a dividend of ₹1.

Welcome to the Investing and Trading Information platform: InvesTrack.in

Note: This platform is for educational and informational purposes only. Do not consider anything as financial advice.

QUICK LINKS

Home
About us
Contact us
Privacy Policy
Disclaimer
Sitemap
Investing
Trading
Top Brokers
Tools
Live Analysis

STAY CONNECTED

Follow Us On Social Media
Get Latest Update On Social Media
Facebook Instagram Twitter

General Disclaimer: InvesTrack is an educational platform and not any type of investment advisory platform. Our Blog and videos are based on countless hours of research and experience, which you can use as a guide for your research purposes. None of our content should be considered a piece of investment advice. Earning Disclosure: InvesTrack is a community supported platform. We may earn a commission when you make a purchase through one of our links at no extra cost to you. Note: We are not SEBI Registered Advisors. This website is purely for training and educational purposes. We shall not be responsible for your profit or loss.

© Copyright 2024 - 2025 | InvesTrack